EUCTR2013-000992-33-DE
Active, Not Recruiting
Phase 1
A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle Sprain
GlaxoSmithKline Consumer Healthcare0 sitesJune 24, 2013
ConditionsPain and inflammation due to Grade I or Grade II acute sprain of the lateral ankleMedDRA version: 17.0Level: PTClassification code 10061218Term: InflammationSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 17.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 17.0Level: PTClassification code 10024453Term: Ligament sprainSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pain and inflammation due to Grade I or Grade II acute sprain of the lateral ankle
- Sponsor
- GlaxoSmithKline Consumer Healthcare
- Status
- Active, Not Recruiting
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Consent: Subject demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- •2\. Age: Subject is from 16 to 65 years of age.
- •3\. Compliance: Subject understands and is willing, able and likely to comply with all study procedures and restrictions.
- •4\. General Health: Subject is in good general and mental health with, in the opinion of the investigator or medically qualified designee:
- •a) No clinically significant and relevant abnormalities of medical history or physical examination.
- •b) No condition that would impact on the subject’s safety or wellbeing or affect his or her ability to understand and follow study procedures and requirements.
- •5\. Diagnosis:
- •a) Subject has a Grade I or Grade II acute sprain of the lateral ankle within 24 hours of Visit 1
- •b) Subject has self\-assessed pain intensity at the site of the ankle sprain that is \= 5 as measured on an 11\-point numerical rating scale
- •c) Subject has a peri\-malleolar edema (sub\-malleolar perimeter difference of \= 20mm between injured and uninjured ankle
Exclusion Criteria
- •1\. Pregnancy: Women who are pregnant or who have a positive urine pregnancy test.
- •2\. Breast\-feeding: Women who are breast–feeding.
- •3\. Subject has treated the ankle sprain with treatment such as oral or other topical pain relief medications, massage or physical therapy since experiencing the ankle sprain. The application of ice to the affected ankle
- •prior to visit 1 is allowed.
- •4\. Subject has other acute or chronic pain disorders, which may confound the study pain evaluations.
- •5\. Subject suffered from a grade I\-III ankle sprain at the same ankle or any other significant injuries (based on investigator’s judgment), or surgeries at the same ankle or foot within 30 days from the current injury. Pain and instability exist at the same ankle due to previous sprain or other trauma. Ligament hyperlaxity occuring at the same ankle due to connective tissue diseases, e.g. Marfan’s syndrome, Down’s syndrome, Ehlers\-Danlos Syndrome, etc.
- •6\. Subject has injury to both ankles or to both medial and lateral ligaments of the same ankle.
- •7\. Allergy/Intolerance: Subject has known or suspected hypersensitivity, allergy, intolerance or contraindication to the use of any of the study medications (or closely related compounds), any of their stated ingredients or any topical medications before.
- •8\. Subject is currently taking or has taken within the previous three months medications or herbal supplements likely, on available evidence, to interfere with the validity of subject\-rated assessments.
- •9\. Subject has a medical history of renal or hepatic disease, a current active peptic ulcer or a history of upper gastrointestinal bleeding or perforation related to previous NSAID therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
A clinical study for evaluating the efficacy and safety of long-term consumption of the honey vinegar beverage on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertensioJPRN-UMIN000016456Soiken Inc.100
Completed
Phase 2
Clinical study to investigate the efficacy and the safety of R-FM for recurrent or refractory indolent B-cell lymphoma - THF016JPRN-UMIN000005442Tohoku Hematology Forum40
Recruiting
N/A
A clinical study to evaluate the effectiveness and safety of HJHP on cognitive function improvementKCT0008744Ewha Womens University80
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Coolief Cooling Radiofrequency Therapy for Chronic Pain after Total Knee Arthroplasty.Prolonged Post-surgical PainTotal Knee Arthroplasty, Prolonged Chronic PainD010149JPRN-jRCTs052230123Matsumoto Tomoyuki6
Completed
Phase 2
A study to determine the efficacy and safety of using remimazolam for dental procedures under sedation.JPRN-jRCTs061220052Kana Oue30